Company intelligence / Profile preview

NovaLign Orthopaedics

Memphis, Tennessee, United Stateszoominfo.com ↗

Ownership: Private
Development stage: Commercial

Overview

NovaLign developed and received FDA clearance for an intramedullary fixation system designed to treat long bone fractures with a minimally invasive approach. The system was marketed following regulatory approval in 2009. In 2011, key assets of the company were acquired by Sonoma Orthopedic Products[1][7][10].

Therapeutic areas: Other
Modalities: DeviceImplantable medical device (specifically intramedullary fixation system)
Industry: Implantable Medical Devices

Partnerships

Versant Ventures (investor)SV Life Sciences / SV Health Investors (investor)Accuitive Medical Ventures (investor)

Beyond the preview

Go deeper on NovaLign Orthopaedics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NovaLign Orthopaedics.

Explore the full profile